Nanocapsules based on mPEGylated artesunate prodrug and its cytotoxicity

Colloids and Surfaces B: Biointerfaces

Volumn 115, Issue , 2014, Pages 164-169

  Meng, Haijing ^a   Xu, Ke ^a   Xu, Yanyun ^a   Luo, Ping ^a   Du, Fang ^a   Huang, Jin ^b   Lu, Wei ^a   Yu, Jiahui ^a   Liu, Shiyuan ^c   Muir, Ben ^d  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY OF TECHNOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d CSIRO   (Australia)

Author keywords

Artesunate; Controllable release; MPEGylation; Nanocapsules; Passive targeting

Indexed keywords

CELL CULTURE; ESTERIFICATION; ESTERS; MOTION PICTURE EXPERTS GROUP STANDARDS; POLYETHYLENE GLYCOLS; TRANSMISSION ELECTRON MICROSCOPY;

ARTESUNATE; AVERAGE PARTICLE SIZE; CONTROLLABLE RELEASE; DYNAMIC LASER SCATTERING; MONOMETHYL ETHERS; MPEGYLATION; NARROW SIZE DISTRIBUTIONS; PASSIVE TARGETING;

NANOCAPSULES;

ARTESUNATE; CISPLATIN; MACROGOL; NANOCAPSULE; PRODRUG; ARTEMISININ DERIVATIVE; MACROGOL DERIVATIVE; MICELLE; MONOMETHOXYPOLYETHYLENE GLYCOL;

AQUEOUS SOLUTION; ARTICLE; CELL VIABILITY; CYTOTOXICITY; ESTERIFICATION; HUMAN; HYDROPHOBICITY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL; ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MCF 7 CELL LINE; MICELLE; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; ULTRASTRUCTURE;

ARTESUNATE;

ANIMALS; ARTEMISININS; CELL DEATH; CELL SURVIVAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MCF-7 CELLS; MICE; MICELLES; NANOCAPSULES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; PRODRUGS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84890262109     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.11.039     Document Type: Article

References (40)

1. Klayman D.L. Science 1985, 228:1049-1055.
2. Posner G.H., Cumming J.N., Ploypradith P., et al. J. Am. Chem. Soc. 1995, 117:5885-5886.
3. Woerdenbag H.J., Moskal T.A., Pras N., et al. J. Nat. Prod. 1993, 56:849-856.
4. Efferth T., Dunstan H., Sauerbrey A., et al. Int. J. Oncol. 2001, 18:767-773.
5. Chen H.H., Zhou H.J., Wu G.D., et al. Pharmacology 2004, 71:1-9.
6. Nakase I., Lai H., Singh N.P., et al. Int. J. Pharm. 2008, 354:28-33.
7. Du J.H., Zhang H.D., Ma Z.J., et al. Cancer Chemoth. Pharmacol. 2010, 65:895-902.
8. Dell'Eva R., Pfeffer U., Vené R., et al. Biochem. Pharmacol. 2004, 68:2359-2366.
9. Chen H., Sun B., Pan S., et al. Anticancer Drugs 2009, 20:131-140.
10. Efferth T., Volm M. In Vivo 2005, 19:225-232.
11. Efferth T., Giaisi M., Merling A., et al. PLoS ONE 2007, 2:693-701.
12. Wu J.M., Shan F., Wu G.S., et al. Eur. J. Med. Chem. 2001, 36:469-479.
13. Lai H., Nakase I., Lacoste E., et al. Anticancer Res. 2009, 29:3807-3810.
14. Lai H., Singh N.P. Cancer Lett. 1995, 91:41-46.
15. Singh N.P., Lai H. Life Sci. 2001, 70:49-56.
16. Singh N.P., Lai H. Anticancer Res. 2004, 24:2277-2280.
17. Luo P., Luo Y., Huang J., et al. Colloids Surf. B 2013, 109:167-175.
18. Kumari A., Yadav S.K., Yadav S.C. Colloids Surf. B 2010, 75:1-18.
19. Guo Q., Luo P., Luo Y., et al. Colloids Surf. B 2012, 100:138-145.
20. Tao S.L., Desai T.A. Adv. Drug Deliv. Rev. 2003, 55:315-328.
21. Mezei M., Gulasekharam V. Life Sci. 1980, 26:1473-1477.
22. Mezei M., Gulasekharam V.J. Pharm. Pharmacol. 1982, 34:473-474.
23. Gregoriadis G. Trends Biotechnol. 1995, 13:527-537.
24. Torchilin V.P. Nat. Rev. Drug Discov. 2005, 4:145-160.
25. Jenning V., Thünemann A.F., Gohla S.H. Int. J. Pharm. 2000, 199:167-177.
26. Malam Y., Loizidou M., Seifalian A.M. Trends Pharmacol. Sci. 2009, 30:592-599.
27. Kataoka K., Harada A., Nagasaki Y. Adv. Drug Deliv. Rev. 2001, 47:113-131.
28. Qiu L.Y., Bae Y.H. Pharm. Res. 2006, 23:1-30.
29. Rosler A., Vandermeulen G.W., Klok H.A. Adv. Drug Deliv. Rev. 2001, 53:95-108.
30. Shen Y., Jin E., Zhang B., et al. J. Am. Chem. Soc. 2010, 132:4259-4265.
31. Parveen S., Sahoo S.K. J. Drug Target. 2008, 16:108-123.
32. Duncan R., Seymour L.W., O'Hare K.B., et al. J. Control. Release 1992, 19:331-346.
33. Carpino L.A. J. Am. Chem. Soc. 1993, 115:4397-4398.
34. Vandana M., Sahoo S.K. Biomaterials 2010, 31:9340-9356.
35. Batty K.T., Davis T.M.E., Thu L.T.A., et al. J. Chromatogr. B 1996, 677:345-350.
36. Yuan F., Leunig M., Huang S.K., Berk D.A., et al. Cancer Res. 1994, 54:3352-3356.
37. Jain R.K. Adv. Drug Deliv. Rev. 1997, 26:71-90.
38. Wu N.Z., Da D., Rudoll T.L., Needham D., et al. Cancer Res. 1993, 53:3765-3770.
39. Zhang X., Du F., Huang J. Colloids Surf. B 2012, 100:155-162.
40. Jiao Y., Tong J. Acta Pharmacol. Sin. 2007, 28:1045-1056.